| ACE | angiotensin-converting enzyme |
| ADHF | acute decompensated heart failure |
| AI | adequate intake |
| ARB | angiotensin receptor blocker |
| BMI | body mass index |
| BP | blood pressure |
| CDC | Centers for Disease Control and Prevention |
| CHF | congestive heart failure |
| CI | confidence interval |
| CKD | chronic kidney disease |
| CT | computed tomography |
| CV | cardiovascular |
| CVD | cardiovascular disease |
| d | day |
| DASH | Dietary Approaches to Stop Hypertension |
| DGA | Dietary Guidelines for Americans |
| DGAC | Dietary Guidelines Advisory Committee |
| DM | diabetes mellitus |
| DRI | Dietary Reference Intake |
| EAR | Estimated Average Requirement |
| eGFR | estimated glomerular filtration rate |
| eNOS | endothelial nitric oxide synthase |
| ESRD | end-stage renal disease |
| FFQ | food frequency questionnaire |
| g | gram |
| h | hour |
| HDL | high-density lipoprotein |
| Hg | mercury |
| HHS | U.S. Department of Health and Human Services |
| HR | hazard ratio |
| IHD | ischemic heart disease |
| IOM | Institute of Medicine |
| IS | ischemic stroke |
| K | potassium |
| kg | kilogram |
| KHANES | Korean Health and Nutrition Examination Survey |
| L | liter |
| LDL | low-density lipoprotein |
| LOAEL | lowest observed adverse effect level |
| LVEF | left ventricular ejection fraction |
| mg | milligram |
| MI | myocardial infarction |
| ml | milliliter |
| mm | millimeter |
| mmol | millimole |
| n | number |
| Na | sodium |
| NHANES | National Health and Nutrition Examination Survey |
| NOAEL | no-observed adverse effect level |
| ONTARGET | ONgoing Telmisartan Alone in combination with Ramipril Global Endpoint Trial |
| PRA | plasma renin activity |
| PURE | Prospective Urban Rural Epidemiology |
| Q | quartile/quintile |
| RAAS | renin-angiotensin-aldosterone system |
| RCT | randomized controlled trial |
| RDA | Recommended Dietary Allowance |
| RR | relative risk |
| SALTURK | Relationship between Hypertension and Salt Intake in Turkish Populations |
| SD | standard deviation |
| TOHP | Trials of Hypertension Prevention |
| TRANSCEND | Telmisartan Randomized AssessmeNt Study in ACE INtolerant subjects with cardiovascular Disease |
| UK | urinary potassium |
| UL | Tolerable Upper Intake Level |
| UNa | urinary sodium |
| USDA | U.S. Department of Agriculture |
| WHO | World Health Organization |